Barrett's Esophagus Risk Factors In Patients without Gastroesophageal Reflux: A Large Population-based Study
Clin Gastroenterol Hepatol
.
2024 Apr 24:S1542-3565(24)00391-4.
doi: 10.1016/j.cgh.2024.03.034.
Online ahead of print.
Authors
Bibek Saha
1
,
Anjul Verma
2
,
Ross Dierkhising
3
,
Rachel Canning
3
,
John B Kisiel
2
,
Prasad G Iyer
4
Affiliations
1
Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
2
Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
3
Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
4
Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Electronic address: iyer.prasad@mayo.edu.
PMID:
38670476
DOI:
10.1016/j.cgh.2024.03.034
No abstract available
Keywords:
Cancer; Esophageal Adenocarcinoma; Gastroesophageal Reflux Disease; Prevalence.